Your browser doesn't support javascript.
loading
Increased Activities against Biofilms of the Pathogenic Yeast Candida albicans of Optimized Pom-1 Derivatives.
Amann, Valerie; Kissmann, Ann-Kathrin; Krämer, Markus; Krebs, Imke; Perez-Erviti, Julio A; Otero-Gonzalez, Anselmo J; Morales-Vicente, Fidel; Rodríguez, Armando; Ständker, Ludger; Weil, Tanja; Rosenau, Frank.
Afiliación
  • Amann V; Institute of Pharmaceutical Biotechnology, Ulm University, Albert-Einstein-Allee 11, 89081 Ulm, Germany.
  • Kissmann AK; Institute of Pharmaceutical Biotechnology, Ulm University, Albert-Einstein-Allee 11, 89081 Ulm, Germany.
  • Krämer M; Institute of Pharmaceutical Biotechnology, Ulm University, Albert-Einstein-Allee 11, 89081 Ulm, Germany.
  • Krebs I; Institute of Pharmaceutical Biotechnology, Ulm University, Albert-Einstein-Allee 11, 89081 Ulm, Germany.
  • Perez-Erviti JA; Center for Protein Studies, Faculty of Biology, University of Havana, 25 Str. and I Str., La Habana 10400, Cuba.
  • Otero-Gonzalez AJ; Center for Protein Studies, Faculty of Biology, University of Havana, 25 Str. and I Str., La Habana 10400, Cuba.
  • Morales-Vicente F; General Chemistry Department, Faculty of Chemistry, University of Havana, Zapata y G, La Habana 10400, Cuba.
  • Rodríguez A; Synthetic Peptides Group, Center for Genetic Engineering and Biotechnology, La Havana 10600, Cuba.
  • Ständker L; Core Facility for Functional Peptidomics, Ulm Peptide Pharmaceuticals (U-PEP), Faculty of Medicine, Ulm University, 89081 Ulm, Germany.
  • Weil T; Core Unit of Mass Spectrometry and Proteomics, Faculty of Medicine, Ulm University, 89081 Ulm, Germany.
  • Rosenau F; Core Facility for Functional Peptidomics, Ulm Peptide Pharmaceuticals (U-PEP), Faculty of Medicine, Ulm University, 89081 Ulm, Germany.
Pharmaceutics ; 14(2)2022 Jan 28.
Article en En | MEDLINE | ID: mdl-35214049

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Pharmaceutics Año: 2022 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Pharmaceutics Año: 2022 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Suiza